Chronic (?)-isoprenaline infusion down-regulates ?1- and ?2-adrenoceptors but does not transregulate muscarinic cholinoceptors in rat heart

Abstract

Regulation of beta-adrenoceptor (beta-ar) subtypes and transregulation of muscarinic cholinoceptors (mAchr) was examined in regions of rat heart after chronic infusion of (-)-isoprenaline (450 micrograms/kg per hour) for 14 days. Following (-)-isoprenaline infusion systolic blood pressure was reduced for 10 days but then gradually returned to control levels, whereas heart rate was increased for 7 days before declining to a level significantly above control. Heart weight to body weight ratio was increased in (-)-isoprenaline treated rats. beta-ar subtype densities were measured by quantitative autoradiography with [125I]-cyanopindolol (CYP) in sinoatrial node (SA), atrioventricular node (AV), bundle of His (BH), left (LB) and right (RB) bundle branches, interventricular (IVS) and interatrial (IAS) septa, right atria (RA), apex (AX) and mitral valve (MV). beta 1-ars were reduced by 59.1-74.2% in the AV conducting regions, 53.4% in the SA node and 43.3-53.4% in myocardial areas, beta 2-ars were markedly reduced in myocardial regions (93.2-98.5%) and in pacemaker and conducting regions (87.7-97.8%). No changes in mAchr densities measured using [3H]-N-methyl scopolamine (NMS) occurred in the AV node, BH, LB, RB, IVS and IAS following (-)-isoprenaline infusion. Densities of beta 1- and beta 2-ars and mAchrs were also measured in ventricular homogenates from control and (-)-isoprenaline treated animals. beta-ar levels were significantly reduced (P < 0.05) in treated animals and the ratio of beta 1- to beta 2-ars increased after treatment. mAchr density in ventricular homogenates measured using either [3H]-NMS or [3H]-quinuclidinyl [phenyl-4-3H]benzilate (QNB) was unchanged. Homogenates of left and right ventricle also showed no change using [3H]-NMS. Organ bath studies were used to investigate the effect of (-)-isoprenaline infusion on negative inotropic and chronotropic effects of the non-selective muscarinic receptor agonist bethanechol in left and right atria, respectively. Lower concentrations of bethanechol (3 x 10(-10) to 10(-6) M) produced a negative inotropic response in isolated electrically driven left atria from (-)-isoprenaline treated rats, but not from control rats, with the slope of the curves being significantly different between groups (ANCOVA, P = 0.037). At concentrations of bethanechol from 10(-6) to 3 x 10(-4) M the negative inotropic response was not changed between (-)-isoprenaline treated and control animals. Bethanechol also produced a negative chronotropic response at lower concentrations (10(-10) to 10(-6) M) in (-)-isoprenaline treated rats, but not in controls. A second, steeper phase of the negative chronotropic response occurred at concentrations of bethanechol greater than 10(-6) M and was also seen in control rats. Expression of M2 (cardiac) mAchrs (m2Achr) in left and right ventricular tissues measured using a quantitative non-competitive polymerase chain reaction (PCR) assay showed a significant (P = 0.001) 28.5% increase in expression in left ventricle and a significant (P = 0.003) 21...

β1-Adrenergic receptors increase UCP1 in human MADS brown adipocytes and rescue cold-acclimated β3-adrenergic receptor-knockout mice via nonshivering thermogenesis

“…However, compared with the experiment situation, where the mice get only one injection of NE, mice living in the cold have a continuous flow of NE stimulating BAT and are therefore capable of producing enough heat to survive the cold. One would speculate that a prolonged exposure to cold (which increases sympathetic outflow) would decrease ␤ 1 -AR levels since continued stimulation of ␤ 1 -ARs in the rat heart results in loss of ␤ 1 -AR numbers and desensitization of the ␤ 1 -AR and also adenylate cyclase pathway (29,31). However, we show in BAT (Fig.…”

Cardiac hypertrophy induced by sustained β-adrenoreceptor activation: pathophysiological aspects

“…Indeed, a reduced heart rate deceleration in response to stimulation of arterial baroreceptors or cardiac chemoreceptors was found in ISO-induced cardiac hypertrophy [70,155]. On the other hand, acetylcholine-induced cardioinhibitory effects as assessed ex vivo were enhanced following chronic ISO administration [35, 155,156]. Taken together, these findings suggest that a reduction of parasympatheticallymediated cardiac effects following chronic ISO administration is related to an impaired integrative function of the brain stem rather than reduced responsiveness of the myocardium to acetylcholine.…”

Cold-impaired cardiac performance in rats is only partially overcome by cold acclimation

“…Ventricle stiffness, inferred from the gradient of the diastolic performance curve, appears to be unchanged by CA, and therefore decreases in developed pressure/RPP are likely to be a consequence of reduced acto-myosin cross-links for increased length sarcomeres. This will preserve stroke volume at the expense of greater residual volume in the ventricle but result in reduced force development; hence, a diminished RPP:CA led to a reduced developed pressure that was only partially recovered by -adrenergic stimulation (dobutamine), suggesting a down-regulation of adrenoreceptor reserve (Cheng and Hauton, 2008) through prolonged catecholamine exposure (Benjamin et al, 1989;Matthews et al, 1996). The poor developed pressure, however, is in contrast to the elevated MABP seen in vivo, suggesting that intrinsic weakness of the myocardium is compensated for physiologically in situ.…”